Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3697458013 | Sodium glycerophosphate 4.32 g/20 mL solution for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3697459017 | Product containing precisely sodium glycerophosphate 4.32 gram/20 milliliter conventional release solution for injection vial (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4168031000052112 | natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | har täljarvärde för koncentrationsstyrka | 216 | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | har täljarvärde som visar styrka | 4.32 (qualifier value) | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Is a | Product containing sodium glycerophosphate (medicinal product) | false | Inferred relationship | Some | ||
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | har nämnarvärde som visar styrka | 20 (qualifier value) | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has precise active ingredient | Sodium glycerophosphate (substance) | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has basis of strength substance (attribute) | Sodium glycerophosphate (substance) | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | Has presentation strength numerator unit | g | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR